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Background: Previous efforts such as Assessing Care of Vulnerable Elders (ACOVE) provide quality indicators for
assessing the care of elderly patients, but thus far little has been done to leverage this knowledge to improve care
for these patients. We describe a clinical decision support system to improve general practitioner (GP) adherence to
ACOVE quality indicators and a protocol for investigating impact on GPs’ adherence to the rules.
Design: We propose two randomized controlled trials among a group of Dutch GP teams on adherence to ACOVE
quality indicators. In both trials a clinical decision support system provides un-intrusive feedback appearing as a
color-coded, dynamically updated, list of items needing attention. The first trial pertains to real-time automatically
verifiable rules. The second trial concerns non-automatically verifiable rules (adherence cannot be established by
the clinical decision support system itself, but the GPs report whether they will adhere to the rules). In both trials
we will randomize teams of GPs caring for the same patients into two groups, A and B. For the automatically
verifiable rules, group A GPs receive support only for a specific inter-related subset of rules, and group B GPs receive
support only for the remainder of the rules. For non-automatically verifiable rules, group A GPs receive feedback
framed as actions with positive consequences, and group B GPs receive feedback framed as inaction with negative
consequences. GPs indicate whether they adhere to non-automatically verifiable rules. In both trials, the main
outcome measure is mean adherence, automatically derived or self-reported, to the rules.
Discussion: We relied on active end-user involvement in selecting the rules to support, and on a model for
providing feedback displayed as color-coded real-time messages concerning the patient visiting the GP at that time,
without interrupting the GP’s workflow with pop-ups. While these aspects are believed to increase clinical decision
support system acceptance and its impact on adherence to the selected clinical rules, systems with these properties
have not yet been evaluated.
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Quality of care in elderly patients
Within the present fragmented healthcare organization,
elderly patients and especially vulnerable elderly patients
with complex problems often receive suboptimal care
coordination and management. This may lead to prema-
ture functional decline or deterioration of quality of life
[1]. Elderly people are in need of an effective, continu-
ous, integrated and comprehensive package of preventive
and curative health care. This requires constant efforts
to assess and improve the quality of their care. The
study, Assessing care of vulnerable elders (ACOVE) has
process-based quality indicators (QI) that comprise a
promising system for the comprehensive assessment of
quality of care. The current version of the indicators,
ACOVE-3, includes 392 indicators. These indicators are
meant to capture minimal standards of care - standards
that, if not met, almost ensure that the care is of poor
quality [2]. These indicators were developed and judged
by clinical experts to improve patient outcomes on the
basis of clinical evidence and professional opinion [2].
The ACOVE QIs are in essence a list of if-then state-
ments, linking a logical condition to a conclusion. The
indicator is adhered to if the conclusion (which is usu-
ally an action) is fulfilled when the indicator is eligible
(that is, when its logical condition is true). Some QIs are
accompanied by an explanation; an example of such a
QI is: ‘If a vulnerable elder is admitted to a hospital or is
new to a physician practice, then multidimensional assess-
ment of cognitive ability and assessment of functional sta-
tus should be documented because screening for dementia
can lead to early detection and initiation of treatment that
may delay further progression.
ACOVE is emerging as an international standard for
quality of care assessment for elderly patients. There are
increasing numbers of studies that have translated the QIs
to various settings [3]. In the Netherlands, the Trimbos
Institute initiated selection and translation of rules rele-
vant for the care of vulnerable elders in Dutch general
practice, resulting in 81 QIs covering eight domains
(dementia, depression, osteoporosis, osteoarthritis, medi-
cation management and use, hearing loss, continuity of
care and falls) [4].
From assessment to improvement
QIs are predominantly used for assessment of quality of
care relatively long after it has been delivered, rather
than directly improving care [3]. It remains unclear how
and to what extent such quality assessment can contribute
to actually improving the quality of care. In our project we
want to exploit QIs to proactively influence physicians’
behavior at the time of care provision. To accomplish this,
we will represent QIs in computer interpretable clinical
rules (CRs) and incorporate them in a real-time clinicaldecision support system (CDSS), integrated in care pro-
viders’ information system. By matching patient data and
physicians’ behavior to the clinical rules, the CDSS can
provide feedback to the physicians in the form of alerts
and reminders. This feedback is meant to help general
practitioners (GPs) adhere to the clinical rules, and
hence to the underlying QIs. Implementation of a
CDSS at the point of care is likely to improve adher-
ence to the clinical rules and thereby improve the overall
quality of care. Currently, however, there are no comput-
erized decision-support approaches to proactively support
physicians for improving care for older patients on a
comprehensive set of QIs aimed at preventing functional
decline.Decision-making tools and appropriate practice/optimal
care delivery
The potential effectiveness of CDSSs has been demon-
strated by various studies [5]. In a series of studies we
have also demonstrated the feasibility and effectiveness
of computer-generated feedback in the Intensive Care
Unit on the quality of care provided [6-8]. However,
computer-generated feedback that is too often irrelevant
or intrusive may result in alert fatigue and irritate cli-
nicians. Alert fatigue is defined as the mental state
that results from too many alerts and expenditure of
mental energy, which can cause relevant alerts to be
unjustifiably overridden along with clinically unim-
portant ones [9]. We relied on active end-user involve-
ment in selecting the rules to support and on a model for
providing feedback displayed as color-coded real-time
messages concerning the patient visiting the GP at
that time, without interrupting the GP’s workflow
with pop-ups. While these aspects are believed to increase
CDSS acceptance and its impact on adherence to the
selected CRs, systems with these properties have not yet
been evaluated.The primary care centers GAZO
In the Netherlands all inhabitants are enlisted with a GP,
who is responsible for comprehensive health care and acts
as a gatekeeper for secondary care. Gezondheidcentra
Amsterdam Zuid-Oost (GAZO) comprises six primary
care health centers in the southeast region of Amsterdam.
A total of 45 GPs work in the GAZO centers (full and
part-time). Every patient belongs to only one GP. How-
ever, when a GP is absent, another GP from a designated
team of GPs may care for his or her patients. The team
consists of pairs or triplets of GPs sharing the care of the
same patients. There is an average of 7,450 (range: 3,285
to 10,055) registered patients in each center. About 10%
of the patients are 65 years or older and about 5% are
75 years or older (data originating from 2009).
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The primary aim of this study is the systematic improve-
ment of the quality of primary care for older persons
(defined as 65 years of age or older) by increasing adher-
ence to the ACOVE-based CRs. To attain this increase
in adherence we intend to use a CDSS that uses the re-
spective CRs in combination with patient and treatment
data to proactively support health care professionals to
make the right decisions at the right time.
Methods
Preparation
Selecting the relevant CRs
We used a modified Delphi method to select the most rele-
vant QIs from the original set of 81 QIs that were trans-
lated to Dutch general practice [4]. Table 1 (Prioritization)
shows the steps of this part of the project. To assess the
perceived need for a QI, we asked GPs whether they would
personally switch decision support for the corresponding
rule on or off. This is a more direct approach to understand
their intention to comply than asking about importance
and relevance of the rules.
Implementability of relevant QIs in computer-based CRs
We recently introduced the logical elements rule method
(LERM) as a step-by-step method for assessing the amen-
ability of CRs for decision support use, and to formalize
the rules in a computer-based form [10]. We use LERM
in this project to identify the implementable QIs and
translate them to CRs in a form usable for a computer
(hereafter referred to simply as CR).
Design and implementation of the CDSS
Table 1 (Design and implementation of CDSS) shows
the different steps of this second part of the project. We
have developed a software module, which is not an inte-
gral part of the GPs’ electronic medical records (EMR).












Measuring baseline 7. Start gat
activatin
Starting the trial 8. Random
9. Tune thetype. We use the same plug-in in our other trial for im-
proving stroke prevention in patients with atrial fibrilla-
tion [11] and shortly describe it here. The CDSS plug-in
can be classified [12] as active (it provides feedback
without being asked to), and non interruptive (it does
not interrupt the workflow of the GP). For most rules it
operates in the critiquing mode (its feedback is based on
deviations from the QIs) but for some rules it works in
the consulting mode by providing timely advice before a
decision has been made. The GPs’ EMR system includes
trigger points reacting on events such as submitting a
medication prescription. These triggers are: opening a
patient's electronic medical record on the computer, the
addition of laboratory data, changing medication, and
updating the patient’s problem list. Such events will trig-
ger sending relevant data to a remote server, called the
clinical rule engine (CRE) via a secure Internet connec-
tion. This information consists of: the data buffer that
holds the information entered or selected by the GP that
is shown on the screen at that moment (such as selec-
tion of a medication) but is not yet saved permanently
to the EMR database, laboratory data from the last
12 months, the active medication list, and a list of the
patient’s diagnoses codes. The CRE evaluates the infor-
mation originating from the EMR by the computerized
decision rules and sends, in response, a message in an
eXtensible markup language (XML) file to the CDSS
plug-in on the GP’s computer. The plug-in extracts the
message title from the XML file, and displays a short-
ened form of the title in a thin sidebar that is attached
to the right side of the GP’s screen. We refer to this
sidebar as the dynamic floating list (DFL) because it is
updated in real-time and can be moved around on the
screen. The GP can move the mouse cursor over the
DFL to display the full message title and can click on it
in order to open the whole message in another window.
The message usually includes advice and relevant find-
ings supporting the advice. In addition, if the GP wishese brief questionnaires among 10 general practitioners (GPs) to select
quality indicators (QIs) out of 81 QIs
result of phase 1 and disagreements in a focus group
e detailed questionnaires among end-users to select clinical rules (CRs)
se in phase 1
riggering points in the GP’s electronic medical record
DSS for selected CRs in CR engine
nt and test CDSS in elecronic medical record
hering the data for selected verifiable CRs and measure baseline before
g the CDSS
ize and pilot CDSS with two users and gather reasons for non adherence
CDSS based on phase 8 and start randomized controlled trial
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to indicate on this window why they do not wish to
adhere to the rule. Upon first appearance, the message
title is displayed with a red background in the DFL, indi-
cating that the message is new. If the GP does not open
the message or does not behave according to its advice,
the background will become orange the next time the
GP opens the EMR, indicating the message has been
shown before but not yet dealt with. For an automatic-
ally verifiable real-time rule, when the GP changes the
treatment plan according to the guideline, the background
will turn green and the message will then disappear. This
can happen without opening the message, for example the
GP might already know that he or she needs to change
the treatment plan and doing so will also result in the
message disappearing, without having to interact with the
CDSS plug-in.
End-user involvement
Social aspects in which computerized applications operate
are thought to be influential on the degree of success of
these applications [13]. In particular, users’ preferences
and concerns should be taken into account in the design
and implementation of such applications. This contributes
to reducing their resistance to the change introduced by
the system. In our project, end users (GPs) are invited to
help select the CRs for which they perceive a genuine need
for decision support, using questionnaires and focus
groups. In addition, we will analyze which factors make
CRs more likely to be selected by GPs for decision support
(such as perceived external social pressure to do well on a
particular CR, high probability of forgetting the action
required by a CR, et cetera).
Baseline measurements
Baseline adherence to automatically verifiable CRs will
be based on data elements residing in the central EMR
database of the primary care centers in GAZO (EMRs of
the GAZO centers are maintained by an external central
server). We will measure baseline adherence based on at
least 24 months prior to the use of the CDSS.
Experiments
This prospective interventional study has a two-
outcome assessor-blinded randomized controlled trial
design (Figure 1). The first trial pertains to verifiable CRs.
Verifiable CRs are ones for which the CRE is able to verify
in real time whether the GP adheres to them or not. For
example, the rule: “If an elder is treated with a non-
steroidal anti-inflammatory drug, then s/he should be
treated concomitantly with either misoprostol or a proton
pump inhibitor” is verifiable because the CRE can estab-
lish whether one of the indicated medications was pre-
scribed. In contrast, consider the CR, “All (vulnerable)elders should have an annual drug regimen review.” This
CR is unverifiable by the CRE because medication review
is not recorded in a structured way in the EMR. The sec-
ond trial pertains to non-automatically verifiable CRs.
For a verifiable CR that is not adhered to, the CRE will
provide a feedback intervention to the GPs for which
the CR is active (that is, the GPs are in the intervention
group for that CR). The feedback implies updating the
items and/or colors of the DFL.
For an unverifiable CR, the only way to establish
whether the GP adheres to it is to ask the GP whether
he or she adheres to the rule. However, because we
cannot establish the extent of adherence to these CRs at
baseline, the CRE will randomize feedback provision
using two types of framing for the advice: framing advice
as action with positive (AP) consequences versus fram-
ing it as inaction with negative (IN) consequences. For
example, for the annual drug regimen review CR de-
scribed above, the AP framing will be: “Documenting
weight loss can allow earlier detection of malignancy
and malnutrition” and the IN framing will be “Failure to
document weight loss can lead to delayed detection of
malignancy and malnutrition.” In this way we will still
be able to compare the (self-reported) adherence to the
rules in both types of framing.
Bias control and randomization
Randomization will take place after measurement of
baseline data. Every CR will be randomized into two
groups of GP teams. Recall that while a patient will usu-
ally be seen by only one GP, a GP team consists of two
or three GPs sharing care for the same sub-population
of patients. When a patient’s official GP is absent,
another GP from the team may see the patient.
Based on the baseline measurement and the ex-
pected room for improvement, randomization at the
GP level is the most appropriate choice in terms of
power and also practicality. However, this randomization
choice will be adapted in order to control for possible
contamination and biases. The discussion below pertains
to verifiable CRs because they are the most prone to
contamination.
We assume that contamination between GPs, espe-
cially in the same center, is relatively high when some
GPs receive support for a rule (intervention) and the
others none (control). To reduce the probability of this
kind of contamination we have two groups of GPs, A
and B. Every GP in group A will receive support for a
specific subset of supported CRs (subset A) and no sup-
port for the rest of the CRs (subset B). By the same
token, Every GP in group B will receive support for
subset B and no support for subset A. This means that
for about half the CRs (subset A) the GPs in group A
form the intervention group and the GPs in group B
Figure 1 Consort diagram of the trial.
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subset B. All GPs will hence receive some kind of support,
which means they do not have to feel that they are in the
control group. A disadvantage of this approach is that
some CRs are inter-related and improvement in one can
explicitly or implicitly lead to improvement in the related
one, even if it is not supported. For example, if one CR is
supported by giving a reminder to order a laboratory test,
and the same laboratory test is required by another CR
that is not supported, ordering the laboratory test will be
registered as adherence to both CRs. Therefore we will
group all inter-related subsets of CRs in either subset A orsubset B, elements of the inter-related subsets will hence
never appear in both groups.
Finally, although patients usually only see their own
GP, the GPs do work in teams. If a patient of one of
these GPs requires an immediate appointment, they may
see another paired GP. To avoid this potential contam-
ination, we will ensure that GPs in a team will be ran-
domized to the same subset. As for the non verifiable
CRs, group-A GPs will receive the AP (action-positive)
framing, and group-B GPs will receive the IN (inaction-
negative) framing. Randomization of GP teams will be
concealed; a person who is not responsible for recruiting
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perform it on a computer.
Participants
Patients
This study will include all patients who are 65 years and
older in six GP centers. Note that although the ACOVE
QIs were meant for vulnerable elders, most of these
rules (and certainly the ones that will be selected) will be
relevant to all elderly patients, vulnerable or not.
Physicians
All GPs in the GAZO centers will be included in the
study. All GPs use the same GP information system in
their practice.
Outcome measure
The main outcome measure is the degree of adherence to
the automatically verifiable clinical rules (regardless of
placement of GPs in teams or centers). Adherence will be
calculated in the following ways: 1) as the first primary
outcome measure, on which the trial will be powered, we
will calculate adherence in terms of the mean pass rate,
without distinguishing between specific rules. For this out-
come we simply divide the number of times any rule was
followed by the number of times any rule was eligible to
be followed; 2) we will calculate the pass rates for each
rule separately as the second primary outcome measure.
The pass rate of a rule is the proportion of times that a
rule was followed when it was eligible; and 3) as a second-
ary outcome we will calculate the number of rules for
which there was effect (the pass rate of a rule in its cor-
responding intervention group was different than in its
control group).
We will also calculate the abovementioned measures
per patient. Measures pertaining to fall prevention and
management will also be investigated separately because
fall management comprises a distinct project in itself.
The main outcome measure for the non-verifiable CRs
is the degree of adherence as reported by the GPs them-
selves. In particular, upon receiving advice the GPs can in-
dicate whether they agree (and hence adhere) or disagree
(and hence not adhere) with the advice. Adherence will be
calculated in the following ways: 1) adherence in terms of
the mean pass rate as the first primary outcome measure;
2) adherence for each rule separately, as the second pri-
mary outcome; and 3) the number of rules for which there
was effect, as a secondary outcome.
Determination of sample size
The determination of sample size is dependent on the
definition of the statistical unit of interest, the estimated
incidence of triggers in the study population and a hy-
pothesis about the effectiveness of the intervention.Statistical unit
The main aim of this study is testing the change in
adherence to the automatically verifiable CRs compared
to the adherence at baseline of GPs, in terms of the
mean pass rate of the rules, and the pass rate per rule.
These CRs belong to different domains of geriatric care.
Therefore, it is meaningful to consider a relevant subset
of the selected verifiable CRs as the main statistical unit
in order to calculate the sample size. This means that we
eventually aim at increasing the average of the adherence
to these CRs.
Hypothesis about the efficacy of the intervention
A case is defined as the situation in which a CR is
eligible, meaning that its logical condition is true. Nu-
merous CRs from the same patient can be assessed, and
eligibility cases of the same CR are considered to be mutu-
ally independent. A power calculation was performed to
determine the number of cases needed to detect a mini-
mally clinically relevant effect of the CDSS based on the
previously published studies. So far, no studies have been
performed that measure the level of adherence to a set of
ACOVE QIs in primary care in The Netherlands but
Wenger et al. [14] showed that a practice-based inter-
vention in the primary-care setting had mean absolute
increase pass rates of 21% (from 23 to 44%) and 15%
(from 22 to 37%) in two sets of ACOVE CRs.
We assumed 40% adherence in the control group
(based on our preliminary baseline analysis) in both verifi-
able and non verifiable CRs. We can hence make a conser-
vative estimate of an absolute increase of 10% in the mean
pass rate of the supported set of CRs in the intervention
group compared to the control group. For non-cluster
randomization, for a power of 0.80, and two-sided testing
at the 0.05 significance level, a total of 408 cases in which
CRs are eligible are required in each group.
Statistical analyses
Because the included CRs in each trial are not compar-
able, we do not compare the result of the verifiable CRs
trial with the non-verifiable CRs trial. During the ana-
lysis plan we therefore did not consider the dependency
between the hypotheses behind the two types of trials.
The chi-square test will be used to compare individual
and sets of CR pass rates between the supported and
non supported automatically verifiable CRs, and between
the CRs with advice that was framed differently (AP and
IN). The binomial test will be used to test whether the
number of supported CRs had higher pass rates than the
non supported CRs. Statistical analyses will be perfor-
med with the R statistical software (R Foundation for
Statistical Computing, Vienna, Austria). Standard statistical
tests will be used to compare the baseline characteristics of
the centers and patients.
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Table 1 shows the sequence of steps in the project. It
started in September 2013, will need at least 6 months
of trial, and we plan to report the results in the third
quarter of 2014 or first quarter of 2015.
Regulatory aspects
The medical ethics committee of the Academic Medical
Center confirmed that the Medical Research Involving
Human Subjects Act (WMO) does not apply to this
study and that an official approval of this study by the
committee is not required. The interventions are simply
different means of giving valid information to physicians.
The trial is supported by two grants from The Netherlands
Organisation for Health Research and Development
(ZonMW). The funder and the software companies in-
volved have no role in study design, data collection and
analysis, or decision to publish on this study. Furthermore,
only anonymized patient data are used for analysis. Every
practice has provided written consent to participate in this
study via a designated GP representative.
Discussion
This study presented an innovative CDSS and described
the protocol for two RCTs to study the effects of decision
support and framing on level of adherence to selected sets
of ACOVE-based CRs in an outpatient setting. The system
is characterized by a non interruptive presentation and
real-time color-coded messages that are promptly updated
based on the GP’s actions.
The CDSS is novel in the sense that it combines all of
the following: it is not interruptive; chooses for a critiquing
or consulting mode per rule; allows for framing advices in
two styles; provides color-coded messages in real time;
allows for understanding why a GP does not choose to
follow a rule; and is based on CRs specifically chosen by
the end users (the GPs) after Delphi-like rounds. We
expect that these aspects will result in increased accept-
ance and thereby improve adherence to CRs. Specifically,
real-time feedback has been correlated with success in
decision-support implementation [15,16]. However, pro-
viding real-time feedback has traditionally been based on
pop-up messages that interrupt the clinicians’ workflow
and contribute to alert fatigue [17] and the perception of
too many alerts is already prevalent among the clinicians
in this study [18].
We considered five main levels of randomization: the
level of the patient, the practitioner, the team, the center,
and the CR. Below we discuss the pros and cons of each.
At the patient level
Randomization at the patient level was considered in-
appropriate for a number of reasons. Most importantly,
it could be confusing to the GPs to receive differentalerts about different patients, and could compromise
patient safety if the practitioner incorrectly interpreted
the absence of an alert that he or she had seen for a pre-
vious patient to mean the absence of that problem in the
current patient.
At the level of GPs
In this scenario, which is our choice, GPs will be
randomly allocated for a set of automatically verifiable
CRs, to one of the two groups: 1) a group receiving
CDSS feedback (intervention group) and 2) a group not
receiving CDSS feedback (control group). For non auto-
matically verifiable CRs, one group will receive the AP
and the other the IN framing. The advantage of this
approach is the large number of individual GPs to be ran-
domly allocated to one of the two groups; this increases
power. A disadvantage is the potential contamination
through the possible exchange of information between
GPs within centers and within teams. In particular, for
verifiable CRs the intervention-group GPs may influence
those in the control group. Similarly, there might be
contamination of the control-group GPs via patients that
were previously seen by the intervention-group GPs, for
example, because the intervention-group GP is absent or
works part-time, and the patient visit is scheduled on an
irregular day for the patient.
At the level of centers
In this scenario clusters are defined as populations of
patients served by the GPs of a primary care center. GP
clusters are randomly allocated to one of two groups: 1)
those receiving CDSS/AP feedback and 2) those without
CDSS/IN feedback (control group). Cluster-randomization
avoids contamination by the effects of possible exchange
of information within a cluster of GPs (center and team).
However, as there are only six GP centers available to
randomize for the current study, a relatively very long
follow-up time would be required to compensate for the
loss of power. In addition, differences between centers in
terms of GPs and patients may necessitate stratifica-
tion of centers during randomization, leading to further
loss of power.
At the level of CRs
In this type of design every CR is randomly assigned to
GPs for decision support: some of the GPs will be in the
intervention/AP group of the CR (receiving feedback or
AP framing about it) and the other GPs will be in the
control/IN group for that CR. This means that every GP
will be in the intervention/AP group for a randomly
selected subset of CRs and in the control/IN group for
the complementary set of CRs. It is very probable that
every GP will have a unique set of CRs for support and
framing, different to any other GP. The advantage is that
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verifiable CRs) to be randomly allocated than centers,
yielding higher power and hence a shorter minimum
follow-up period required to detect an effect. The dis-
advantage is that contamination between GPs is still
possible. However, an additional problem is that the
CRs can be inter-related (for example because they
pertain to the same condition, such as falls), which
leads to contamination, because support for one CR
may not only influence the GPʼs behavior for that CR
but also for other, related CRs, even if they are not sup-
ported. The CRs must therefore be grouped together and
all CRs in each group should either be supported or not.
In effect, we then have a cluster-randomized trial in which
the cluster consists of the CR groups. Hence the power
disadvantages apply again due to the low number of
resulting clusters (groups of CRs) and the possible need to
stratify randomization to have similar GP and patient
characteristics for each cluster.Trial status
Upon submission of this paper the CDSS plug-in was
under development and testing. It was employed in late
September 2013. Data collection, hence including patients,
started from October 1st 2013, and the study will run for
at least 6 months.
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